ING Group
BDRX icon

ING Group’s Biodexa Pharmaceuticals BDRX Stock Holding History

ING Group’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Hold
0
– -$85K – 503
2019
Q2 		– Hold
0
– – – 737

Other funds holding BDRX

CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return